| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
16,686 |
15,164 |
$1.65M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
14,318 |
13,277 |
$949K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,346 |
6,099 |
$667K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,142 |
5,910 |
$650K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
4,100 |
3,960 |
$445K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
25,605 |
16,183 |
$401K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
3,705 |
3,479 |
$357K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,898 |
2,708 |
$298K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
4,642 |
4,363 |
$176K |
| 99188 |
|
14,748 |
14,145 |
$154K |
| 92552 |
|
11,278 |
10,881 |
$145K |
| 97803 |
|
12,040 |
11,632 |
$144K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
14,598 |
13,668 |
$86K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,323 |
5,884 |
$81K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
2,471 |
2,317 |
$43K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,177 |
7,501 |
$35K |
| 99381 |
|
483 |
417 |
$35K |
| 96160 |
|
27,860 |
14,755 |
$29K |
| 94150 |
|
5,147 |
4,339 |
$28K |
| 85018 |
|
22,931 |
21,978 |
$24K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
4,809 |
4,431 |
$24K |
| 99383 |
|
254 |
245 |
$22K |
| 99051 |
|
3,728 |
3,535 |
$19K |
| 99382 |
|
166 |
152 |
$13K |
| 99496 |
|
334 |
320 |
$11K |
| 92567 |
|
2,992 |
2,664 |
$11K |
| 87807 |
|
1,924 |
1,793 |
$8K |
| 90677 |
|
195 |
182 |
$8K |
| 96127 |
|
5,027 |
3,761 |
$8K |
| 99384 |
|
72 |
69 |
$7K |
| 83655 |
|
1,815 |
1,725 |
$6K |
| 0072A |
|
142 |
137 |
$6K |
| 99201 |
|
58 |
46 |
$5K |
| 0002A |
|
138 |
135 |
$5K |
| 0001A |
|
187 |
177 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
60 |
49 |
$5K |
| 0071A |
|
152 |
135 |
$4K |
| 90671 |
|
19 |
19 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,707 |
1,597 |
$3K |
| 90670 |
|
2,487 |
2,398 |
$2K |
| 90716 |
|
1,489 |
1,425 |
$2K |
| 94760 |
|
4,253 |
3,632 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
437 |
384 |
$2K |
| 90619 |
|
34 |
30 |
$1K |
| 90686 |
|
4,011 |
3,837 |
$1K |
| 96161 |
|
1,921 |
1,709 |
$976.72 |
| 90633 |
|
1,663 |
1,587 |
$721.92 |
| 90697 |
|
12 |
12 |
$628.20 |
| 99173 |
|
13,505 |
12,018 |
$562.72 |
| 90674 |
|
186 |
184 |
$376.43 |
| 90700 |
|
3,634 |
3,509 |
$338.15 |
| 81002 |
|
451 |
402 |
$302.40 |
| 90707 |
|
1,405 |
1,346 |
$287.55 |
| 94664 |
|
160 |
127 |
$266.53 |
| 90648 |
|
2,252 |
2,164 |
$228.62 |
| 90651 |
|
2,368 |
2,253 |
$194.96 |
| 90713 |
|
2,842 |
2,737 |
$181.70 |
| 90687 |
|
93 |
93 |
$179.23 |
| 91307 |
|
315 |
246 |
$178.98 |
| 90744 |
|
1,161 |
1,059 |
$142.45 |
| S8110 |
Peak expiratory flow rate (physician services) |
28 |
26 |
$67.14 |
| 90620 |
|
745 |
688 |
$60.00 |
| 91300 |
|
304 |
271 |
$40.00 |
| 90688 |
|
381 |
374 |
$36.04 |
| 90685 |
|
74 |
68 |
$30.00 |
| A7015 |
Aerosol mask, used with dme nebulizer |
123 |
99 |
$24.44 |
| 90656 |
|
112 |
109 |
$23.60 |
| 81003 |
|
15 |
14 |
$10.10 |
| 99499 |
|
1,375 |
1,102 |
$1.04 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
14 |
13 |
$0.90 |
| 90715 |
|
355 |
335 |
$0.00 |
| 90681 |
|
816 |
785 |
$0.00 |
| G9919 |
Screening performed and positive and provision of recommendations |
1,913 |
1,847 |
$0.00 |
| 90734 |
|
1,281 |
1,224 |
$0.00 |
| 90461 |
|
142 |
106 |
$0.00 |
| 99072 |
|
1,249 |
1,109 |
$0.00 |
| 80061 |
Lipid panel |
17 |
16 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
14 |
14 |
$0.00 |
| 3008F |
|
8,286 |
6,497 |
$0.00 |
| 1111F |
|
242 |
195 |
$0.00 |
| 36416 |
|
481 |
470 |
$0.00 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
40 |
34 |
$0.00 |